Bill Snyder Archive — Page 99 of 121
-
November 20, 2014
Receptor discovery shines new light on appetite regulation
A receptor in the brain that regulates appetite and body weight has now been found in L cells, key regulatory cells in the gut, providing the pharmaceutical industry with a novel drug target for both obesity and diabetes, a Vanderbilt University-led research team reported this week. -
November 13, 2014
Speaker explores promise of ‘bioelectronic medicine’
Can an implanted electrical device like a cardiac pacemaker effectively treat inflammatory diseases like rheumatoid arthritis, including cases that have not responded to drug therapy? -
November 11, 2014
Protein “pockets” help ID cancer genes
Vanderbilt investigators have used a computational biology approach to uncover new cancer drivers and biomarkers of anticancer drug response. -
November 6, 2014
Cox to lead trans-institutional genetics efforts
Nancy J. Cox, Ph.D., professor of Medicine and Human Genetics and chief of the Section of Genetic Medicine at the University of Chicago, has been appointed founding director of a new genetics institute at Vanderbilt University, effective Jan. 1, 2015. -
November 6, 2014
Autonomic diseases consortium lands renewed federal funding
A nationwide research group headed by Vanderbilt University’s David Robertson, M.D., has received another round of funding from the federal government to continue studies of rare neurodegenerative diseases and disorders affecting blood pressure. -
November 6, 2014
BioVU to collect plasma in hunt for heart failure clues
Vanderbilt’s biobank, BioVU, has begun to collect and store plasma, the liquid part of blood, to aid studies of diseases ranging from heart failure and hypertension to breast cancer.